Mobile

Inhaled human insulin with the AERx® iDMS as prandial monotherapy compared to combination therapy with metformin and glimepiride in type 2 diabetes: an eighteen-week, open-label, multicentre, randomis...

Mise à jour : Il y a 4 ans
Référence : EUCTR2006-004623-12

Inhaled human insulin with the AERx® iDMS as prandial monotherapy compared to combination therapy with metformin and glimepiride in type 2 diabetes: an eighteen-week, open-label, multicentre, randomised, parallel group trial with an eight-week extension to investigate efficacy and safety

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To compare the effect of periprandial inhaled insulin administered with AERx with the effect of glimepiride and metformin combination therapy, on glycaemic control after 18 weeks of treatment (as measured by change in HbA1c from baseline) in previously inadequately controlled subjects with type 2 diabetes.

Critère d'inclusion

  • Type 2 Diabetes

Liens